Compare TCBK & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCBK | ADMA |
|---|---|---|
| Founded | 1975 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 1995 | 2012 |
| Metric | TCBK | ADMA |
|---|---|---|
| Price | $52.78 | $11.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $57.84 | $17.00 |
| AVG Volume (30 Days) | 223.8K | ★ 2.7M |
| Earning Date | 10-22-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.73% | N/A |
| EPS Growth | ★ 6.94 | N/A |
| EPS | ★ 2.10 | 0.35 |
| Revenue | ★ $53,445,000.00 | $42,219,783.00 |
| Revenue This Year | $7.81 | $4.93 |
| Revenue Next Year | $4.06 | $17.59 |
| P/E Ratio | ★ $25.10 | $31.93 |
| Revenue Growth | 4.12 | ★ 43.85 |
| 52 Week Low | $43.22 | $7.21 |
| 52 Week High | $61.71 | $20.46 |
| Indicator | TCBK | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 51.91 | 64.75 |
| Support Level | $52.34 | $8.31 |
| Resistance Level | $53.05 | $11.37 |
| Average True Range (ATR) | 0.98 | 0.33 |
| MACD | 0.21 | 0.03 |
| Stochastic Oscillator | 60.38 | 86.42 |
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income. Its banking and financial services are provided through full-service branches and commercial banking offices across California.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.